Grant: Discovery Grants Program - Individual
McGill University
$52,000.00
Macromolecular platform for functional nanomaterials
EF 2023-24
Résumé
Synthetic polymers have been widely utilized in manufacturing products that have become an integral part of modern society, and find applications in developing materials for electronics, automotive industry, energy storage, packaging etc. Managing and preventing high morbidity rate diseases using carriers for lipophilic drugs (referred to as nanomedicine), is another area where polymers continue to offer tremendous potential. However, basic issues related to i) the efficacy of polymeric nanoparticles (NPs) in delivering controlled and sustained drug dosages at desired sites; and ii) how the interactions of drug-loaded nanocarriers with biological media upon entry into the blood stream influence their drug release profiles, still remain. The lack of knowledge of these critical factors has become a key obstacle in clinical translation. We are addressing these significant challenges through synthetic articulation of polymers and by developing a detailed understanding of their structure-property relationships. To design nanoparticles that can carry out precisely defined tasks, we shall develop synthetic methodologies to new amphiphilic branched polymers which could i) undergo temperature controlled reversible changes in their morphologies; and ii) respond to local biological environment, and either degrade, followed by assembly into smaller drug reservoirs; or form linked nanoparticle colonies through aqueous coupling chemistry. Such polymeric NPs will release required drug doses over longer time scales. Polymeric formulations upon administration and entry into blood circulation are generally exposed to biomacromolecules that quickly form a protein layer on the NP surface. We shall synthesize new polymeric backbones that will yield NPs with varied surface shell density, functional groups and stimuli-responsive chemical entities. Through their detailed evaluation, we shall develop a deeper understanding of the crucial role protein corona build-up plays on the drug release profiles of NPs. Using an interdisciplinary approach of our polymer chemistry program, this DG will i) advance fundamental knowledge and contribute missing links in developing efficient polymeric formulations; ii) facilitate technology transfer in nanomedicine development; and iii) train highly qualified personnel with transferable skills to academia and industry.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-03565
Name nom
Kakkar, Ashok
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
52000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Macromolecular platform for functional nanomaterials
Keyword
Architectural polymers; Bio-nano interactions; Drug delivery; Macromolecules; Metal nanoparticles; Miktoarm polymers; Nanoformulations; Polymers; Polymer self-assembly; Soft nanoparticles
Application summary
Synthetic polymers have been widely utilized in manufacturing products that have become an integral part of modern society, and find applications in developing materials for electronics, automotive industry, energy storage, packaging etc. Managing and preventing high morbidity rate diseases using carriers for lipophilic drugs (referred to as nanomedicine), is another area where polymers continue to offer tremendous potential. However, basic issues related to i) the efficacy of polymeric nanoparticles (NPs) in delivering controlled and sustained drug dosages at desired sites; and ii) how the interactions of drug-loaded nanocarriers with biological media upon entry into the blood stream influence their drug release profiles, still remain. The lack of knowledge of these critical factors has become a key obstacle in clinical translation. We are addressing these significant challenges through synthetic articulation of polymers and by developing a detailed understanding of their structure-property relationships. To design nanoparticles that can carry out precisely defined tasks, we shall develop synthetic methodologies to new amphiphilic branched polymers which could i) undergo temperature controlled reversible changes in their morphologies; and ii) respond to local biological environment, and either degrade, followed by assembly into smaller drug reservoirs; or form linked nanoparticle colonies through aqueous coupling chemistry. Such polymeric NPs will release required drug doses over longer time scales. Polymeric formulations upon administration and entry into blood circulation are generally exposed to biomacromolecules that quickly form a protein layer on the NP surface. We shall synthesize new polymeric backbones that will yield NPs with varied surface shell density, functional groups and stimuli-responsive chemical entities. Through their detailed evaluation, we shall develop a deeper understanding of the crucial role protein corona build-up plays on the drug release profiles of NPs. Using an interdisciplinary approach of our polymer chemistry program, this DG will i) advance fundamental knowledge and contribute missing links in developing efficient polymeric formulations; ii) facilitate technology transfer in nanomedicine development; and iii) train highly qualified personnel with transferable skills to academia and industry.